Hcw Biologics Stock Price Prediction
| HCWB Stock | USD 0.77 0.06 8.45% |
Oversold Vs Overbought
33
Oversold | Overbought |
Wall Street Target Price 3 | Quarterly Revenue Growth (0.01) |
Using HCW Biologics hype-based prediction, you can estimate the value of HCW Biologics from the perspective of HCW Biologics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in HCW Biologics to buy its stock at a price that has no basis in reality. In that case, they are not buying HCW because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
HCW Biologics after-hype prediction price | USD 0.81 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
HCW |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of HCW Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
HCW Biologics After-Hype Price Prediction Density Analysis
As far as predicting the price of HCW Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in HCW Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of HCW Biologics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
HCW Biologics Estimiated After-Hype Price Volatility
In the context of predicting HCW Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on HCW Biologics' historical news coverage. HCW Biologics' after-hype downside and upside margins for the prediction period are 0.04 and 42.91, respectively. We have considered HCW Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
HCW Biologics is out of control at this time. Analysis and calculation of next after-hype price of HCW Biologics is based on 3 months time horizon.
HCW Biologics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as HCW Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HCW Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with HCW Biologics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
4.23 | 42.10 | 0.04 | 0.11 | 5 Events / Month | 8 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.77 | 0.81 | 5.19 |
|
HCW Biologics Hype Timeline
HCW Biologics is currently traded for 0.77. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.11. HCW is anticipated to increase in value after the next headline, with the price projected to jump to 0.81 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 5.19%, whereas the daily expected return is currently at 4.23%. The volatility of related hype on HCW Biologics is about 156371.43%, with the expected price after the next announcement by competition of 0.88. HCW Biologics currently holds about 32.41 M in cash with (22.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days. Check out HCW Biologics Basic Forecasting Models to cross-verify your projections.HCW Biologics Related Hype Analysis
Having access to credible news sources related to HCW Biologics' direct competition is more important than ever and may enhance your ability to predict HCW Biologics' future price movements. Getting to know how HCW Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how HCW Biologics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ANEB | Anebulo Pharmaceuticals | (0.07) | 6 per month | 0.00 | (0.02) | 8.85 | (11.48) | 76.00 | |
| RZLT | Rezolute | 0.18 | 8 per month | 3.10 | 0.03 | 6.81 | (5.54) | 30.01 | |
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.18) | 6.21 | (9.35) | 34.87 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 5.15 | (0.01) | 9.61 | (8.53) | 52.92 | |
| MNOV | MediciNova | 0.16 | 9 per month | 4.13 | 0.11 | 14.50 | (8.50) | 61.30 | |
| CSBR | Champions Oncology | (0.24) | 6 per month | 3.87 | (0.02) | 6.23 | (6.96) | 22.49 | |
| CYT | Cyteir Therapeutics | 0.09 | 2 per month | 2.57 | 0.08 | 10.00 | (5.26) | 36.14 | |
| PMVP | Pmv Pharmaceuticals | (0.1) | 3 per month | 2.12 | (0.02) | 3.75 | (3.77) | 13.98 | |
| PHVS | Pharvaris BV | (0.23) | 5 per month | 2.98 | 0.06 | 7.76 | (6.02) | 21.41 | |
| PEPG | PepGen | 0.39 | 9 per month | 0.00 | (0.28) | 4.75 | (9.02) | 26.81 | |
| PRDS | Pardes Biosciences | 0.02 | 3 per month | 1.66 | 0.1 | 4.28 | (2.59) | 15.31 | |
| STTK | Shattuck Labs | (0.01) | 7 per month | 0.00 | (0.15) | 7.03 | (9.82) | 52.02 | |
| IPSC | Century Therapeutics | 0.01 | 9 per month | 0.00 | (0.11) | 6.21 | (8.82) | 23.66 |
HCW Biologics Additional Predictive Modules
Most predictive techniques to examine HCW price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for HCW using various technical indicators. When you analyze HCW charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About HCW Biologics Predictive Indicators
The successful prediction of HCW Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as HCW Biologics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of HCW Biologics based on analysis of HCW Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to HCW Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to HCW Biologics's related companies. | 2010 | 2023 | 2024 (projected) | Dividend Yield | 0.034 | 0.0306 | 0.0272 | Price To Sales Ratio | 56.4 | 15.55 | 30.12 |
Story Coverage note for HCW Biologics
The number of cover stories for HCW Biologics depends on current market conditions and HCW Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that HCW Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about HCW Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
HCW Biologics Short Properties
HCW Biologics' future price predictability will typically decrease when HCW Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of HCW Biologics often depends not only on the future outlook of the potential HCW Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HCW Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 35.9 M | |
| Cash And Short Term Investments | 3.6 M |
Complementary Tools for HCW Stock analysis
When running HCW Biologics' price analysis, check to measure HCW Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HCW Biologics is operating at the current time. Most of HCW Biologics' value examination focuses on studying past and present price action to predict the probability of HCW Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HCW Biologics' price. Additionally, you may evaluate how the addition of HCW Biologics to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |